# K152945: Alevicyn SG Antipruritic Gel

- Pathway: 510(k) (Traditional)
- Applicant: Oculus Innovative Sciences
- Decided: Dec 15, 2015 after 70 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K830708 (1983). 22 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 26 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K143590: Alevicyn SG Antipruritic Gel, Oculus Innovative Sciences (2015) Summary page 4.
- K121134: TL Triseb Cream, Trigen Laboratories, Inc. (2012) Summary page 4.
- K123724: Dermiseb Cream, Igi Laboratories, Inc. (2013) Summary page 4.
- K120730: Loutrex Topical Cream, Acella Pharmaceuticals, LLC (2012) Summary page 4.

## Most influential descendants
- K171935: Alevicyn SG Antimicrobial Gel (2017), 1 descendant of its own
- K173896: Microcyn Antimicrobial Hydrogel (2018), 0 descendants of its own
- K162217: LOYON (2017), 0 descendants of its own

## Indications for use
Under the supervision of a health care professional, Alevicyn SG Gel is indicated to manage and relieve the burning, itching, erythema, scaling, and pain experienced with various types of dermatoses, including atopic dermatitis, radiation dermatitis, and seborrhea and seborrheic dermatitis. Alevicyn SG Gel may be also used to relieve the pain of first and second degree burns. Alevicyn SG Gel helps to relieve dry waxy skin by maintaining a moist wound & skin environment, which is beneficial to the healing process.

Source page: https://510kreport.com/device/K152945
Methodology: https://510kreport.com/methodology